ACELRX PHARMACEUTICALS INC
New Filing
CIK: 0001427925·Pharmaceuticals·DELAWARE·Filed: Aug 17, 2022
Total Offering
$629,958
Amount Sold
$629,958
Investors
1
First Sale
Aug 3, 2022
Offering Details
- Type
- Equity, Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Vincent J. Angotti | Related Person |
| Pamela P. Palmer | Related Person |
| Raffi Asadorian | Related Person |
| Badri Dasu | Related Person |
| Adrian Adams | Related Person |
| Richard Afable | Related Person |
| Jill Broadfoot | Related Person |
| Marina Bozilenko | Related Person |
| Stephen J. Hoffman | Related Person |
| Howard B. Rosen | Related Person |
| Mark Wan | Related Person |
Company
SEC Filing
0001427925-22-000001
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free